Evidence map›Paper›PMID 20978172›Full record

SynthesisCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis.

Jonathan D Kocarnik, Carolyn M Hutter, Martha L Slattery, Sonja I Berndt, Li Hsu, David J Duggan, Jill Muehling, Bette J Caan, Shirley A A Beresford, Aleksandar Rajkovic and 9 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. F-box only protein 9 and its role in cancer.Molecular biology reports · 2022
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Gene-environment interaction involving recently identified colorectal cancer susceptibility Loci.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  16. Article
  17. Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Jonathan D KocarnikDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Carolyn M Hutter
Martha L Slattery
Sonja I Berndt
Li Hsu
David J Duggan
Jill Muehling
Bette J Caan
Shirley A A Beresford
Aleksandar Rajkovic
Gloria E Sarto
James R Marshall
Nazik Hammad
Robert B Wallace
Karen W Makar
Ross L Prentice
John D Potter
Richard B Hayes
Ulrike Peters
Fred Hutch Cancer Center · USNational Cancer Institute · USNational Institutes of Health · USTranslational Genomics Research Institute · US

Funding

Women's Health Initiative Clinical Coordinating CenterN01WH22110 · WH · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRENTICE, ROSS L · 2007 to 2010
$22.5M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
Genome-Wide Association Study of Nonsynonymous SNPs in Colon CancerR01CA059045 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 1994 to 2011
$11.5M
Use of Biomarkers in Diagnosis, Prognosis, Risk Prediction and Early Detection ofP01CA053996 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRENTICE, ROSS L · 1991 to 2015
$9.4M
DIET, ACTIVITY &REPRODUCTION--RISKS FOR RECTAL CANCERR01CA048998 · NCI · UNIVERSITY OF UTAH · PI SLATTERY, MARTHA L · 1991 to 2012
$7.9M
Cancer Prevention Trng-Nutrition, Exercise &GeneticsR25CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2002 to 2016
$7.3M
Statistical Methods in Genetic EpidemiologyR01AG014358 · NIA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2002 to 2013
$2.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042119 · WH · YESHIVA UNIVERSITY · PI WASSERTHEIL-SMOLLER, SYLVIA · 1994 to 2001
$2.2M
Prospective Study on Selenium, Genectics of Selenoenzymes, and Colorectal CancerR01CA120582 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2006 to 2014
$2.1M
VANGUARD CENTER FOR WOMEN'S HEALTH INITIATIVEN01WH032111 · WH · EMORY UNIVERSITY · PI WATTS, NELSON · 1993 to 2001
$1.6M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042123 · WH · MEDSTAR RESEARCH INSTITUTE · PI HOWARD, BARBARA V · 1994 to 2000
$1.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042109 · WH · STANFORD UNIVERSITY · PI STEFANICK, MARCIA L · 1994 to 2000
$1.4M
Intramural NIH HHSNCI NIH HHS K22 CA118421NCI NIH HHS P01 CA053996NCI NIH HHS P01 CA53996NCI NIH HHS R01 CA048998NCI NIH HHS R01 CA059045NCI NIH HHS R01 CA120582NCI NIH HHS R01 CA48998NCI NIH HHS R25 CA094880NCI NIH HHS U01 CA137088NIA NIH HHS R01 AG014358NIA NIH HHS R01 AG14358PHS HHS 24152PHS HHS 32100-2PHS HHS 32105-6PHS HHS 32108-9PHS HHS 32111-13PHS HHS 32115PHS HHS 32118-32119PHS HHS 32122PHS HHS 42107-26PHS HHS 42129-32PHS HHS 44221WHI NIH HHS N01 WH022110WHI NIH HHS N01 WH024152WHI NIH HHS N01 WH032100WHI NIH HHS N01 WH032102WHI NIH HHS N01 WH032105WHI NIH HHS N01 WH032106WHI NIH HHS N01 WH032108WHI NIH HHS N01 WH032109WHI NIH HHS N01 WH032111WHI NIH HHS N01 WH032112WHI NIH HHS N01 WH032113WHI NIH HHS N01 WH032115WHI NIH HHS N01 WH032118WHI NIH HHS N01 WH032119WHI NIH HHS N01 WH032122WHI NIH HHS N01 WH042107WHI NIH HHS N01 WH042108WHI NIH HHS N01 WH042109WHI NIH HHS N01 WH042110WHI NIH HHS N01 WH042111WHI NIH HHS N01 WH042112WHI NIH HHS N01 WH042113WHI NIH HHS N01 WH042114WHI NIH HHS N01 WH042115WHI NIH HHS N01 WH042116WHI NIH HHS N01 WH042117WHI NIH HHS N01 WH042119WHI NIH HHS N01 WH042120WHI NIH HHS N01 WH042121WHI NIH HHS N01 WH042122WHI NIH HHS N01 WH042123WHI NIH HHS N01 WH042124WHI NIH HHS N01 WH042125WHI NIH HHS N01 WH042126WHI NIH HHS N01 WH042129WHI NIH HHS N01 WH042130WHI NIH HHS N01 WH042131WHI NIH HHS N01 WH042132WHI NIH HHS N01 WH044221WHI NIH HHS N01WH22110
6 · The paper itself

Abstract

backgroundA potential susceptibility locus for colorectal cancer on chromosome 9p24 (rs719725) was initially identified through a genome-wide association study, though replication attempts have been inconclusive.

methodsWe genotyped this locus and explored interactions with known risk factors as potential sources of heterogeneity, which may explain the previously inconsistent replication. We included Caucasians with colorectal adenoma or colorectal cancer and controls from 4 studies (total 3,891 cases, 4,490 controls): the Women's Health Initiative (WHI); the Diet, Activity and Lifestyle Study (DALS); a Minnesota population-based case-control study (MinnCCS); and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). We used logistic regression to evaluate the association and test for gene-environment interactions.

resultsSNP rs719725 was statistically significantly associated with risk of colorectal cancer in WHI (OR per A allele 1.19; 95% CI, 1.01-1.40; P(trend) = 0.04), marginally associated with adenoma risk in PLCO (OR per A allele 1.11; 95% CI, 0.99-1.25; P(trend) = 0.07), and not associated in DALS and MinnCCS. Evaluating for gene-environment interactions yielded no consistent results across the studies. A meta-analysis of 17 studies (including these 4) gave an OR per A allele of 1.07 (95% CI, 1.03-1.12; P(trend) = 0.001).

conclusionsOur results suggest the Aallele for SNP rs719725 at locus 9p24 is positively associated with a small increase in risk for colorectal tumors. Environmental risk factors for colorectal cancer do not appear to explain heterogeneity across studies. IMPACT: If this finding is supported by further replication and functional studies, it may highlight new pathways underlying colorectal neoplasia.

Indexed as

Genetic Predisposition to DiseaseAdenomaAgedChromosomes, Human, Pair 9Colorectal NeoplasmsFemaleGenetic LociGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID20978172
PMCPMC3005543
OpenAlexW2130615734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.